Search
Patexia Research
Case number 2016-1085

Allergan, Inc. v. Sandoz, Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 ALLERGAN, INC. v. SANDOZ, INC. [OPINION] [nonprecedential] (0)
Apr 24, 2017 93 Mandate issued to the United States District Court for the Middle District of North Carolina. Service as of this date by Clerk of Court. [426446] [16-1085, 16-1160] [SJ] [Entered: 04/24/2017 09:10 AM] (2)
Mar 17, 2017 92 OPINION and JUDGMENT filed. The judgment or decision is: Affirmed-in-Part, Reversed-in-Part. (Nonprecedential Opinion). (For the Court: Reyna,Circuit Judge; Wallach,Circuit Judge and Chen,Circuit Judge). [416485] [16-1085, 16-1160] [SJ] [Entered: 03/17/2017 09:21 AM] (19)
Feb 8, 2017 91 Submitted after ORAL ARGUMENT by Craig E. Countryman for Allergan, Inc. and John J. Molenda for Sandoz, Inc., Akorn, Inc., Apotex Corp., Apotex, Inc., and Hi-Tech Pharmacal Co., Inc. Panel: Judge: Reyna , Judge: Wallach , Judge: Chen. [405551] [JAB] [Entered: 02/08/2017 10:43 AM] (0)
Jan 24, 2017 90 AMENDED Response to oral argument order from the Appellees Akorn, Inc., Apotex Corp., Apotex, Inc., Hi-Tech Pharmacal Co., Inc. and Sandoz, Inc.. designating John Josef Molenda as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [401340] [John Molenda] [Entered: 01/24/2017 12:07 PM] (0)
Jan 24, 2017 89 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [88], ERROR: Counsel for appellee Hi-Tech Pharmacal Co., Inc. submitted a response to the oral argument order indicating 0 minutes for argument and 0 minutes for rebuttal. CORRECTION: If you would like to waive oral argument, you must select the proper form of waiver from the drop-down list when submitting your response to oral argument order. If one attorney is arguing on behalf of all appellees, he or she must file a response to oral argument order that indicates all of the parties he or she is arguing for. Please submit corrected responses by midnight on the date of this notice. [401257] [JAB] [Entered: 01/24/2017 10:51 AM] (0)
Jan 24, 2017 88 Response to oral argument order from the Appellee Hi-Tech Pharmacal Co., Inc.. designating Sailesh K. Patel as arguing attorney. Designated time for argument: 0 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [401255] [Sailesh Patel] [Entered: 01/24/2017 10:48 AM] (0)
Jan 24, 2017 87 Notice to counsel for Appellee Hi-Tech Pharmacal Co., Inc.: The record of this case indicates that the Response to Oral Argument Order has not been filed. The response was due on or before 1/17/2017. Counsel should promptly docket the Response to Oral Argument Order event and designate which attorney will present argument for the party. Service as of this date by Clerk of Court. [401239] [JAB] [Entered: 01/24/2017 10:41 AM] (0)
Jan 24, 2017 86 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [84], calendar response Docket No. [85], ERROR: Counsel for appellees Akorn, Inc., Apotex Corp. and Apotex, Inc. submitted responses to the oral argument order indicating 0 minutes for argument and 0 minutes for rebuttal. CORRECTION: If you would like to waive oral argument, you must select the proper form of waiver from the drop-down list when submitting your response to oral argument order. If one attorney is arguing on behalf of all appellees, he or she must file a response to oral argument order that indicates all of the parties he or she is arguing for. Please submit corrected responses by midnight on the date of this notice. [401108] [JAB] [Entered: 01/24/2017 08:41 AM] (0)
Jan 17, 2017 85 AMENDED Response to oral argument order from the Appellee Akorn, Inc.. designating Sailesh K. Patel as arguing attorney. Designated time for argument: 0 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [399732] [Sailesh Patel] [Entered: 01/17/2017 09:22 PM] (0)
Jan 17, 2017 84 Response to oral argument order from the Appellees Apotex Corp. and Apotex, Inc.. designating Deanne M. Mazzochi as arguing attorney. Designated time for argument: 0 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [399708] [William Rakoczy] [Entered: 01/17/2017 06:03 PM] (0)
Jan 17, 2017 83 Response to oral argument order from the Appellee Sandoz, Inc.. designating John Josef Molenda as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [399674] [John Molenda] [Entered: 01/17/2017 04:27 PM] (0)
Jan 17, 2017 82 Response to oral argument order from the Appellee Akorn, Inc.. designating Sailesh K. Patel as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [399668] [Sailesh Patel] [Entered: 01/17/2017 04:26 PM] (0)
Jan 13, 2017 81 Response to oral argument order from the Appellant Allergan, Inc.. designating Craig E. Countryman as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [399055] [Craig Countryman] [Entered: 01/13/2017 01:27 PM] (0)
Jan 5, 2017 80 Entry of appearance for John Josef Molenda as of counsel for Appellee Sandoz, Inc.. Service: 01/05/2017 by email. [396527] [John Molenda] [Entered: 01/05/2017 04:09 PM] (2)
Dec 15, 2016 79 NOTICE OF CALENDARING. Panel: 1702E. Case scheduled Feb 08, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 01/17/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [391326] THIS NOTICE APPLIES TO CASE(S): [16-1085, 16-1121, 16-1739, 16-1761] [JAB] [Entered: 12/15/2016 12:14 PM] (0)
Nov 8, 2016 78 Notice from Appellee Sandoz, Inc. regarding conflicts with oral argument (March 6-10, 2017). Service: 11/08/2016 by email. [381304] [Thomas Filarski] [Entered: 11/08/2016 02:12 PM] (2)
Nov 8, 2016 77 Notice from Appellee Sandoz, Inc. regarding conflicts with oral argument (March 6-10, 2017). Service: 11/08/2015 by email. [381298] [Thomas Filarski] [Entered: 11/08/2016 02:01 PM] (2)
Nov 8, 2016 76 NOTICE OF DEFICIENCY: The party letter Document No. [75] filed by Appellee Sandoz, Inc. in 16-1085 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [381211] [SJ] [Entered: 11/08/2016 11:01 AM] (0)
Nov 3, 2016 75 Notice from Appellee Sandoz, Inc. regarding conflicts with oral argument (March 6-10, 2017). Service: 11/03/2016 by email. [380268] [Thomas Filarski] [Entered: 11/03/2016 11:31 PM] (0)
Nov 2, 2016 74 Notice from Appellees Apotex Corp. and Apotex, Inc. regarding conflicts with oral argument (December 5-9, 2016; January 9-13, 2017). Service: 11/02/2016 by email. [379819] [William Rakoczy] [Entered: 11/02/2016 03:47 PM] (2)
Aug 11, 2016 73 **TEXT ONLY** ORDER granting motion to withdraw attorney William Ward, III [72] filed by Appellees Apotex Corp. and Apotex, Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [357958] [SJ] [Entered: 08/11/2016 09:41 AM] (0)
Aug 10, 2016 72 MOTION of Appellees Apotex Corp. and Apotex, Inc. to withdraw counsel William Ward, III. Response/Opposition is due 08/25/2016 [Consent: unopposed]. Service: 08/10/2016 by email. [357828] [William Rakoczy] [Entered: 08/10/2016 04:47 PM] (5)
Aug 5, 2016 71 **TEXT ONLY** ORDER granting motion to withdraw attorney Henry Behnen [70] filed by Appellees Hi-Tech Pharmacal Co., Inc. and Akorn, Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [356579] [SJ] [Entered: 08/05/2016 03:34 PM] (0)
Aug 4, 2016 70 MOTION of Appellees Akorn, Inc. and Hi-Tech Pharmacal Co., Inc. to withdraw counsel Henry Behnen. Response/Opposition is due 08/18/2016 [Consent: unopposed]. Service: 08/04/2016 by email. [356153] [Sailesh Patel] [Entered: 08/04/2016 12:05 PM] (5)
Aug 4, 2016 69 CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account(s) of Henry Behnen for Hi-Tech Pharmacal Co., Inc. and Akorn, Inc. The e-mail address associated with your CM/ECF account has generated a delivery failure notice. Pursuant to Fed. Cir. R. 47.3(c)(1), counsel should promptly update his account information with the Pacer Service Center. If the attorney is no longer associated with the case, counsel should promptly move to withdraw the attorney (see Fed. Cir. R. 47.3(c)(5)). [356028] [IW] [Entered: 08/04/2016 07:48 AM] (0)
Jul 28, 2016 68 Amended Certificate of Interest for the Appellant Allergan, Inc.. Service: 07/28/2016 by email. [354457] [Craig Countryman] [Entered: 07/28/2016 06:37 PM] (2)
Jul 28, 2016 67 Entry of appearance for Craig E. Countryman as of counsel for Appellant Allergan, Inc.. Service: 07/28/2016 by email. [354456] [Craig Countryman] [Entered: 07/28/2016 06:35 PM] (2)
Jul 27, 2016 66 Notice from Appellees Akorn, Inc. and Hi-Tech Pharmacal Co., Inc. regarding conflicts with oral argument (September 7-9 and October 3-7). Service: 07/27/2016 by email. [354136] [Sailesh Patel] [Entered: 07/27/2016 05:18 PM] (1)
Jul 27, 2016 65 Notice from Appellee Sandoz, Inc. regarding conflicts with oral argument (September 7-9 and October 3-7). Service: 07/27/2016 by email. [354115] [Thomas Filarski] [Entered: 07/27/2016 04:16 PM] (2)
Jul 27, 2016 64 Notice from Appellees Apotex Corp. and Apotex, Inc. regarding conflicts with oral argument (September 6-9, 2016; October 3-7, 2016; December 5-9, 2016). Service: 07/27/2016 by email. [354103] [William Rakoczy] [Entered: 07/27/2016 04:02 PM] (2)
Jul 27, 2016 63 Notice from Appellant Allergan, Inc. regarding conflicts with oral argument (trials in October and December). Service: 07/27/2016 by email. [354062] [Jonathan Singer] [Entered: 07/27/2016 02:44 PM] (2)
Jul 25, 2016 62 6 paper copies of the Nonconfidential Joint Appendix (Vol. I-II) [59] received from Appellant Allergan, Inc. [353441] [KW] [Entered: 07/25/2016 04:13 PM] (0)
Jul 25, 2016 61 6 paper copies of the Confidential Joint Appendix (Vol. I-II) [58] received from Appellant Allergan, Inc. [353439] [KW] [Entered: 07/25/2016 04:05 PM] (0)
Jul 20, 2016 60 Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice of Conflict with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 07/27/2016. [352401] [SJ] [Entered: 07/20/2016 03:59 PM] (0)
Jul 18, 2016 59 APPENDIX FILED for Allergan, Inc. [56]. Number of Pages: 1068. Service: 07/18/2016 by email. Pursuant to Fed. Cir. R. 30(a)(5), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/25/2016. [352400] [SJ] [Entered: 07/20/2016 03:57 PM] (1072)
Jul 18, 2016 58 CONFIDENTIAL JOINT APPENDIX FILED for Allergan, Inc. [55]. Number of Pages: 1068. Service: 07/18/2016 by email. Pursuant to Fed. Cir. R. 28(d)(2)(A) six paper copies should be filed of the confidential version only. [352398] [SJ] [Entered: 07/20/2016 03:53 PM] (0)
Jul 18, 2016 57 Statement of Compliance with Fed. Cir. R. 33 for Appellant Allergan, Inc. and Appellees Akorn, Inc., Apotex Corp., Apotex, Inc., Hi-Tech Pharmacal Co., Inc. and Sandoz, Inc.. Service: 07/18/2016 by email. [351747] [Deanna Reichel] [Entered: 07/18/2016 04:40 PM] (7)
Jul 18, 2016 56 TENDERED from Appellant Allergan, Inc.. Title: JOINT APPENDIX. Service: 07/18/2016 by email. [351746] [Deanna Reichel] [Entered: 07/18/2016 04:38 PM] (1072)
Jul 18, 2016 55 TENDERED from Appellant Allergan, Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 07/18/2016 by email. [351743] [Deanna Reichel] [Entered: 07/18/2016 04:35 PM] (0)
Jul 12, 2016 54 6 paper copies of the Reply Brief [53] received from Appellant Allergan, Inc. [350379] [KW] [Entered: 07/13/2016 09:30 AM] (0)
Jul 8, 2016 53 REPLY BRIEF FILED for Appellant Allergan, Inc. [52]. Number of Pages: 23. Service: 07/08/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/13/2016. Appendix is due 07/18/2016. [349555] [SJ] [Entered: 07/08/2016 04:32 PM] (30)
Jul 8, 2016 52 TENDERED from Appellant Allergan, Inc.. Title: REPLY BRIEF. Service: 07/08/2016 by email. [349544] [Jonathan Singer] [Entered: 07/08/2016 04:10 PM] (30)
Jun 21, 2016 51 **TEXT ONLY** ORDER granting motion to withdraw attorney Thomas Rammer [50] filed by Appellee Sandoz, Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [345499] [SJ] [Entered: 06/21/2016 04:19 PM] (0)
Jun 21, 2016 50 MOTION of Appellee Sandoz, Inc. to withdraw counsel Thomas A. Rammer II. Response/Opposition is due 07/05/2016 [Consent: unopposed]. Service: 06/21/2016 by email. [345478] [Thomas Filarski] [Entered: 06/21/2016 03:42 PM] (4)
Jun 16, 2016 49 CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account(s) of Mr. Thomas Arthur Rammer, II for Sandoz, Inc. The e-mail address associated with your CM/ECF account has generated a delivery failure notice. Pursuant to Fed. Cir. R. 47.3(c)(1), counsel should promptly update his account information with the Pacer Service Center. If the attorney is no longer associated with the case, counsel should promptly move to withdraw the attorney (see Fed. Cir. R. 47.3(c)(5)). [344004] [IW] [Entered: 06/16/2016 07:41 AM] (0)
Jun 15, 2016 48 Entry of appearance for Gretchen P. Miller as of counsel for Appellee Sandoz, Inc.. Service: 06/15/2016 by email. [343774] [Gretchen Miller] [Entered: 06/15/2016 12:24 PM] (2)
Jun 10, 2016 47 **TEXT ONLY** ORDER granting motion to extend time to file reply brief [46] filed by Appellant Allergan, Inc. Reply brief is due 07/08/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [342389] [SJ] [Entered: 06/10/2016 08:53 AM] (0)
Jun 9, 2016 46 MOTION of Appellant Allergan, Inc. to extend the time to 07/08/2016 to file the reply brief. Response/Opposition is due 06/23/2016 [Consent: unopposed]. Service: 06/09/2016 by email. [342234] [Jonathan Singer] [Entered: 06/09/2016 02:45 PM] (7)
Jun 3, 2016 45 6 paper copies of the Response Brief [44] received from Appellees. [341930] [MJL] [Entered: 06/08/2016 03:07 PM] (0)
Jun 1, 2016 44 BRIEF FILED for Appellees Akorn, Inc., Apotex Corp., Apotex, Inc., Hi-Tech Pharmacal Co., Inc. and Sandoz, Inc. [43]. Number of Pages: 52. Service: 06/01/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 06/07/2016. Appellant Allergan, Inc. reply brief is due 06/20/2016. [340293] [SJ] [Entered: 06/02/2016 01:00 PM] (70)
Jun 1, 2016 43 TENDERED from Appellees Akorn, Inc., Apotex Corp., Apotex, Inc., Hi-Tech Pharmacal Co., Inc. and Sandoz, Inc.. Title: RESPONSE BRIEF. Service: 06/01/2016 by email. [339995] [Sailesh Patel] [Entered: 06/01/2016 03:18 PM] (70)
Apr 28, 2016 42 CORRECTED ENTRY: **TEXT ONLY** ORDER granting motion to extend time to file appellees' principal brief [41] filed by Appellees Apotex Corp. and Apotex, Inc. Appellees' brief(s) due 06/01/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [330491]--[Edited 04/28/2016 by SJ - Reason: to correct due date; to reflect extension for all appellees] [SJ] [Entered: 04/28/2016 04:18 PM] (0)
Apr 28, 2016 41 MOTION of Appellees Apotex Corp. and Apotex, Inc. to extend the time to 06/01/2016 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 05/12/2016 [Consent: unopposed]. Service: 04/28/2016 by email. [330350] [William Rakoczy] [Entered: 04/28/2016 02:03 PM] (9)
Mar 29, 2016 40 6 paper copies of the Opening Brief [39] received from Appellant Allergan, Inc.. [322548] [LAJ] [Entered: 03/29/2016 03:27 PM] (0)
Mar 25, 2016 39 BRIEF FILED for Appellant Allergan, Inc. [38]. Number of Pages: 27. Service: 03/25/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/04/2016. Appellees Akorn, Inc., Apotex Corp., Apotex, Inc., Hi-Tech Pharmacal Co., Inc. and Sandoz, Inc. brief is due 05/09/2016. [321960] [JCA] [Entered: 03/28/2016 08:37 AM] (70)
Mar 25, 2016 38 TENDERED from Appellant Allergan, Inc.. Title: OPENING BRIEF. Service: 03/25/2016 by email. [321853] [Deanna Reichel] [Entered: 03/25/2016 03:14 PM] (70)
Feb 23, 2016 37 ORDER granting motion to extend time to file appellant's opening brief [36] filed by Appellant Allergan, Inc. The brief is due March 25, 2016. Service: 02/23/2016 by clerk. [313179] [LMS] [Entered: 02/23/2016 10:40 AM] (2)
Feb 19, 2016 36 MOTION of Appellant Allergan, Inc. to extend the time to 03/25/2016 to file the appellant/petitioner's principal brief. Response/Opposition is due 03/03/2016 [Consent: partial consent]. Service: 02/19/2016 by email. [312509] [Deanna Reichel] [Entered: 02/19/2016 03:35 PM] (8)
Dec 4, 2015 35 **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [34] filed by Appellant Allergan, Inc. Brief due 03/04/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [293772] [SJ] [Entered: 12/04/2015 04:37 PM] (0)
Dec 4, 2015 34 MOTION of Appellant Allergan, Inc. to extend the time to 03/04/2016 to file the appellant/petitioner's principal brief. Response/Opposition is due 12/17/2015 [Consent: unopposed]. Service: 12/04/2015 by email. [293737] [Deanna Reichel] [Entered: 12/04/2015 03:12 PM] (8)
Dec 3, 2015 33 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Apotex Corp. and Apotex, Inc.. Service: 12/03/2015 by US mail, email. [293501] [William Rakoczy] [Entered: 12/03/2015 05:46 PM] (4)
Dec 3, 2015 32 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Allergan, Inc.. Service: 12/03/2015 by email. [293471] [Deanna Reichel] [Entered: 12/03/2015 04:20 PM] (2)
Dec 3, 2015 31 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Akorn, Inc. and Hi-Tech Pharmacal Co., Inc.. Service: 12/03/2015 by email. [293305] [Sailesh Patel] [Entered: 12/03/2015 12:03 PM] (3)
Dec 3, 2015 30 Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Sandoz, Inc.. Service: 12/03/2015 by email. [293296] [Thomas Filarski] [Entered: 12/03/2015 11:38 AM] (3)
Nov 17, 2015 29 Docketing Statement for the Appellees Apotex Corp. and Apotex, Inc.. Service: 11/17/2015 by US mail, email. [289484] [William Rakoczy] [Entered: 11/17/2015 02:14 PM] (5)
Nov 17, 2015 28 Certificate of Interest for the Appellees Apotex Corp. and Apotex, Inc.. Service: 11/17/2015 by US mail, email. [289481] [William Rakoczy] [Entered: 11/17/2015 02:12 PM] (3)
Nov 17, 2015 27 Entry of appearance for William F. Ward as of counsel for Appellees Apotex Corp. and Apotex, Inc.. Service: 11/17/2015 by US mail, email. [289480] [William Rakoczy] [Entered: 11/17/2015 02:10 PM] (3)
Nov 17, 2015 26 Entry of appearance for Luke T. Shannon as of counsel for Appellees Apotex Corp. and Apotex, Inc.. Service: 11/17/2015 by US mail, email. [289479] [William Rakoczy] [Entered: 11/17/2015 02:09 PM] (3)
Nov 17, 2015 25 Entry of appearance for Joseph T. Jaros as of counsel for Appellees Apotex Corp. and Apotex, Inc.. Service: 11/17/2015 by US mail, email. [289478] [William Rakoczy] [Entered: 11/17/2015 02:07 PM] (3)
Nov 17, 2015 24 Entry of appearance for Deanne M. Mazzochi as principal counsel for Appellees Apotex Corp. and Apotex, Inc.. Service: 11/17/2015 by US mail, email. [289477] [William Rakoczy] [Entered: 11/17/2015 02:05 PM] (3)
Nov 17, 2015 23 Entry of appearance for William A. Rakoczy as of counsel for Appellees Apotex Corp. and Apotex, Inc.. Service: 11/17/2015 by US mail, email. [289475] [William Rakoczy] [Entered: 11/17/2015 02:01 PM] (3)
Nov 17, 2015 22 Amended Docketing Statement for the Appellant Allergan, Inc.. Service: 11/17/2015 by email. [289380] [Deanna Reichel] [Entered: 11/17/2015 10:51 AM] (4)
Nov 6, 2015 21 Official caption revised pursuant to 11/6/15 court order. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [286822] [SJ] [Entered: 11/06/2015 09:14 AM] (0)
Nov 6, 2015 20 Note to file: The following cases are associated:16-1085 (lead) with 16-1160 (consol.). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [286811] [16-1085, 16-1160] [SJ] [Entered: 11/06/2015 09:07 AM] (0)
Nov 6, 2015 19 ORDER consolidating appeals (16-1085 & 16-1160), modifying the official caption. Appellant's brief is due 01/04/2016. Service as of this date by Clerk of Court. [286798] [16-1085, 16-1160] [SJ] [Entered: 11/06/2015 08:56 AM] (2)
Nov 3, 2015 18 Corrected Docketing Statement for the Appellee Sandoz, Inc.. Service: 11/03/2015 by email. [285881] [Thomas Filarski] [Entered: 11/03/2015 05:39 PM] (4)
Nov 3, 2015 17 NOTICE OF DEFICIENCY: The docketing statement Document No. [15] filed by Appellee Sandoz, Inc. in 16-1085 the form is incomplete and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [285488] [JAB] [Entered: 11/03/2015 08:05 AM] (0)
Nov 2, 2015 16 Entry of appearance for Thomas A. Rammer, II as of counsel for Appellee Sandoz, Inc.. Service: 11/02/2015 by email. [285424] [Thomas Rammer] [Entered: 11/02/2015 05:44 PM] (2)
Nov 2, 2015 15 Docketing Statement for the Appellee Sandoz, Inc.. Service: 11/02/2015 by email. [285422] [Thomas Filarski] [Entered: 11/02/2015 05:41 PM] (4)
Nov 2, 2015 14 Certificate of Interest for the Appellee Sandoz, Inc.. Service: 11/02/2015 by email. [285421] [Thomas Filarski] [Entered: 11/02/2015 05:41 PM] (2)
Nov 2, 2015 13 Entry of appearance for Thomas J. Filarski as principal counsel for Appellee Sandoz, Inc.. Service: 11/02/2015 by email. [285420] [Thomas Filarski] [Entered: 11/02/2015 05:40 PM] (2)
Nov 2, 2015 12 Corrected Certificate of Interest for the Appellant Allergan, Inc.. Service: 11/02/2015 by email. [285330] [Deanna Reichel] [Entered: 11/02/2015 03:21 PM] (2)
Nov 2, 2015 11 Entry of appearance for Elizabeth M. Flanagan as of counsel for Appellant Allergan, Inc.. Service: 11/02/2015 by email. [285319] [Elizabeth Flanagan] [Entered: 11/02/2015 03:08 PM] (2)
Nov 2, 2015 10 Docketing Statement for the Appellant Allergan, Inc.. Service: 11/02/2015 by email. [285317] [Deanna Reichel] [Entered: 11/02/2015 03:03 PM] (4)
Nov 2, 2015 9 Certificate of Interest for the Appellant Allergan, Inc.. Service: 11/02/2015 by email. [285316] [Deanna Reichel] [Entered: 11/02/2015 03:03 PM] (2)
Nov 2, 2015 8 Entry of appearance for Deanna J. Reichel as of counsel for Appellant Allergan, Inc.. Service: 11/02/2015 by email. [285314] [Deanna Reichel] [Entered: 11/02/2015 03:01 PM] (2)
Nov 2, 2015 7 Entry of appearance for Jonathan E. Singer as principal counsel for Appellant Allergan, Inc.. Service: 11/02/2015 by email. [285311] [Jonathan Singer] [Entered: 11/02/2015 02:57 PM] (2)
Nov 2, 2015 6 Docketing Statement for the Appellees Akorn, Inc. and Hi-Tech Pharmacal Co., Inc.. Service: 11/02/2015 by email. [285183] [Sailesh Patel] [Entered: 11/02/2015 12:32 PM] (4)
Nov 2, 2015 5 Certificate of Interest for the Appellees Akorn, Inc. and Hi-Tech Pharmacal Co., Inc.. Service: 11/02/2015 by email. [285182] [Sailesh Patel] [Entered: 11/02/2015 12:30 PM] (2)
Nov 2, 2015 4 Entry of appearance for Henry P. Behnen as of counsel for Appellees Akorn, Inc. and Hi-Tech Pharmacal Co., Inc.. Service: 11/02/2015 by email. [285181] [Sailesh Patel] [Entered: 11/02/2015 12:28 PM] (2)
Nov 2, 2015 3 Entry of appearance for Joel M. Wallace as of counsel for Appellees Akorn, Inc. and Hi-Tech Pharmacal Co., Inc.. Service: 11/02/2015 by email. [285180] [Sailesh Patel] [Entered: 11/02/2015 12:27 PM] (2)
Nov 2, 2015 2 Entry of appearance for Sailesh K. Patel as principal counsel for Appellees Akorn, Inc. and Hi-Tech Pharmacal Co., Inc.. Service: 11/02/2015 by email. [285179] [Sailesh Patel] [Entered: 11/02/2015 12:26 PM] (2)
Oct 19, 2015 1 Appeal docketed. Received: 10/14/2015. [281379]Entry of Appearance due 11/02/2015. Certificate of Interest is due on 11/02/2015. Docketing Statement due 11/02/2015. [LN] [Entered: 10/19/2015 11:53 AM] (27)
Menu